The Amerian Heart Association and the Duke Clinical Research Institute have formed a strategic alliance devoted to designing and conducting pragmatic randomized clinical trials in the cardiovascular space.

A study published in the November issue of the Journal of the American College of Cardiology confirms that patients defined as “very high risk” for future ASCVD events by updated society guidelines do indeed carry a much higher risk of adverse outcomes down the road.

Nearly 93% of the U.S. population lives in a hospital referral region with at least one medical center that performs 25 or more mitral valve repairs or replacements each year, according to work published in JAMA Cardiology—but MVRR centers continue to suffer from significant geographical and patient-level disparities.

American counties hit hardest by the Great Recession saw a sharp increase in deaths from CVD and stroke that wasn’t mirrored in communities that experienced less economic distress, according to a new study.

A group of researchers in the U.K. reported this week that even slight increases in a person’s cardiac troponin levels predict adverse outcomes—including early death—in patients of all ages.

A study presented at the American Heart Association’s Scientific Sessions in Philadelphia this November found that heart patients who practiced routine intermittent fasting over a period of four and a half years were ultimately healthier than those who didn’t.

People trained to perform CPR with a virtual reality tool were able to achieve comparable chest compression rates as those trained face-to-face in a recent randomized study—but the VR approach still has a long way to go.